Brief: Orgenesis Announces Cell-Based Vaccine Platform Targeting COVID-19 And Other Existing And Emerging Viral Diseases
13/05/2020 19:25
May 13 (Reuters) - Orgenesis Inc ORGS.O :
* ORGENESIS ANNOUNCES CELL-BASED VACCINE PLATFORM TARGETING
COVID-19 AND OTHER EXISTING AND EMERGING VIRAL DISEASES
* ORGENESIS INC - IS MOVING FORWARD WITH PLANNED ANIMAL
TESTING
FOR ITS CELL-BASED VACCINE PLATFORM IN COVID-19
* ORGENESIS INC - HAS NOT YET SUBMITTED ANY SUCH PLANS OR
DATA TO
FDA OR ANY OTHER REGULATORY BODY
Source text for Eikon: urn:newsml:reuters.com:*:nGNX9rmjFr
Further company coverage: ORGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orgenesis
See all newsBrief: Orgenesis Nasdaq To Delist Co'S Common Stock, Securities Trading Will Be Suspended On Oct 21
Brief: Orgenesis Announces Positive Results From A Real-World Study Of Org-101 Car-T Therapy
Brief: Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group
Brief: Orgenesis Says Entered Purchase Deal With Theracell For Purchase Of 50% Outstanding Ownership Rights & Equity Interests In Theracell Laboratories Ike
Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules